Continuous glucose monitoring versus conventional glucose monitoring in the ICU: A randomized controlled trial.
J Crit Care
; 84: 154894, 2024 Aug 05.
Article
em En
| MEDLINE
| ID: mdl-39106581
ABSTRACT
PURPOSE:
This study evaluated the clinical utility of continuous glucose monitoring system (CGMS) in critically ill patients.METHODS:
In this randomized controlled trial, we randomly assigned critically ill participants with diabetes or stress-induced hyperglycemia to the CGMS group (n = 48) or to the conventional point-of-care monitoring (POCM) group (n = 48). The glucose values and clinical outcome were compared between the two group. The primary endpoint was 28-day mortality after intensive care unit admission.RESULTS:
The 28-day mortality was not significantly different between the CGMS and POCM group (20.8% vs 31.3%, P = 0.25). The mean glucose, time-weighted average glucose, glucose standard deviation and time in range (3.9-10.0) were significantly improved in the CGMS group (all P < 0.05).CONCLUSION:
Compared with conventional POCM, CGMS did not decrease the 28-day mortality in critically ill participants with diabetes or stress-induced hyperglycemia. But CGMS may improve the glycemic control and may be increasingly used in critically ill patients.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article